Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Initially the hypothalamic factor responsible for the release of corticotropin (CRF), was thought to be a simple peptide. More recent work has led to the conclusion that CRF is a multifactorial complex. In 1979 we proposed that vasopressin, much disputed as a CRF candidate, was a major constituent of the complex, interacting with a potentiating the CRF activity of the other component(s). The recent characterization of a 41 residue ovine hypothalamic peptide capable of releasing adrenocorticotropic hormone (ACTH) in a dose-related manner has allowed us to compare its CRF bioactivity with that of vasopressin and simple extracts of the hypothalamus, and to investigate any interaction it may have with vasopressin and other hypothalamic factors in the release of ACTH. We report here that the new CRF is more potent than vasopressin in releasing ACTH. When given simultaneously with vasopressin a fourfold potentiation of CRF activity with steep dose-response characteristics were observed. It also potentiated vasopressin-free hypothalamic extracts, suggesting that a new CRF does not account for all the nonvasopressin portion of the CRF complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Their synergistic stimulation of ACTH production and secretion by corticotrope cells could yield a several-fold higher output than due to the action of either one individually (26, 34–41, 43–47).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, it has been indicated that both CRH and AVP act on their own receptors (28–32) on corticotrope cells in anterior pituitary to stimulate adrenocorticotropic hormone (ACTH) production and release with different (26, 33–41) or even similar potencies (42).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, both in human (39, 43–47, 55) and in rat (26, 36–38, 40, 41), CRH reaction pathway is considered to be dominant in pituitary-adrenal regulation.”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Corticotropin-releasing hormone and AVP interact at the level of the anterior pituitary (16)”
From Progesterone does not alter osmotic regulation of AVP (2001) · cites this paper as [16]
In the citing paper
“Furthermore, VP stimulates adrenocorticotropin hormone release through the activation of pituitary V1bR [10,11].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Schally, A. V., Arimura, A., & Kastin, A. J. (1973) · Science · doi:10.1126/science.179.4071.341 · Cited by 572
Frontiers in Neuroendocrinology
Ball, J. B. (1975) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197501000-00019 · Cited by 426
FRONTIERS IN NEUROENDOCRINOLOGY
Kennedy, G. C. (1970) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.33.5.719 · Cited by 357
Corticotrophin releasing factor may be modulated vasopressin
GILLIES, G., & LOWRY, P. (1979) · Nature · doi:10.1038/278463a0 · Cited by 174
Self-citationHypothalamic Releasing Factors
Burgus, R. C., & Guillemin, R. (1970) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.39.070170.002435 · Cited by 129
Gillies, G. E., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-521 · Cited by 106
Self-citationZimmerman, E. A., Stillman, M. A., Recht, L. D., Antunes, J. L. F., Carmel, P. W., & Goldsmith, P. C. (1977) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1977.tb41872.x · Cited by 97
Gillies, G. E., Greidanus, T. B. V. W., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-528 · Cited by 60
Self-citation
Research works printed but not linked: 5
- Royce, P. C. & Sayers, G. Proc. Soc. exp. Biol. Med. 142, 842–845 (1960).
- Gillies, G. & Lowry, P. J. in Interactions within the Brain-Pituitary-Adrenocortical System (eds Jones, Gilham, Dallman & Chattopadhyay) 51–61 (Academic, New York, 1979).
- Sokol, H. W. & Zimmerman, E. A. Ann. N.Y. Acad. Sci. (in the press).
- Zimmerman, E. A. in Frontiers of Neuroendocrinology Vol. 4 (eds Martini, L. & Ganong, W. F.) 25–62 (Raven, New York, 1976).
- Baertischi, A. in Neuroendocrinology of Vasopressin, Corticoliberin and Opiomelanocortin (eds Baertischi, A. & Driefuss, J.-J.) (Academic, London, in the press).
Cited by
Items 301–400 of 971
MILSOM, S. R., CONAGLEN, J. V., DONALD, R. A., ESPINER, E. A., NICHOLLS, M. G., & LIVESEY, J. H. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb02998.x · Cited by 66
Perraudin, V. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.9.2661 · Cited by 68
Stefanakis, K., Upadhyay, J., Ramirez-Cisneros, A., Patel, N., Sahai, A., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156056 · Cited by 75
Identification and characterization of arginine vasopressin-like substances in the rat testis.
Kasson, B. G., Meidan, R., & Hsueh, A. J. W. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89022-6 · Cited by 65
Pulsatile activation of the hypothalamic-pituitary-adrenal axis during major surgery
Calogero, A. E., Norton, J. A., Sheppard, B. C., Listwak, S. J., Cromack, D. T., Wall, R. T., Jensen, R. T., & Chrousos, G. P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90164-6 · Cited by 74
Gaillard, R. C., Schoenenberg, P., Favrod-Coune, C. A., Muller, A. F., Marie, J., Bockaert, J., & Jard, S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.9.2907 · Cited by 64
Coen, C. W., Montagnese, C., & Opacka‐Juffry, J. (1990) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1990.tb00839.x · Cited by 65
Arginine Vasopressin (AVP) and AVP-Like Immunoreactivity in Peripheral Tissues
CLEMENTS, J. A., & FUNDER, J. W. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-4-449 · Cited by 65
Mormède, P. (1983) · Nature · doi:10.1038/302345a0 · Cited by 65
Interaction of Stress, Corticotropin-Releasing Factor, Arginine Vasopressin and Behaviour
Beurel, E., & Nemeroff, C. B. (2014) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2014_306 · Cited by 64
“CRF is thought to mediate the acute stress response in cooperation with AVP (Gillies et al., 1982; Jaferi and Bhatnagar, 2007; Lightman, 2008; Ma et al., 1997; van Gaalen et al., 2002).”
BackgroundRhythmicity matters: Circadian and ultradian patterns of HPA axis activity
Focke, C. M. B., & Iremonger, K. J. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110652 · Cited by 68
Madison, F. N., Jurkevich, A., & Kuenzel, W. J. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.08.014 · Cited by 71
Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders
Keck, M. E., Ohl, F., Holsboer, F., & Müller, M. B. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.003 · Cited by 73
Tsukahara, Tsukamura, Foster, & Maeda (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00312.x · Cited by 65
Modulation of social behavior by distinct vasopressin sources
Rigney, N., Vries, G. J. D., & Petrulis, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1127792 · Cited by 68
Toufexis, Tesolin, Huang, & Walker (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00381.x · Cited by 65
Aubry¶, Bartanusz¶, Jezova, Belin, & Kiss (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00338.x · Cited by 63
Windows into stress: a glimpse at emerging roles for CRH PVN neurons
Rasiah, N. P., Loewen, S. P., & Bains, J. S. (2023) · Physiological Reviews · doi:10.1152/physrev.00056.2021 · Cited by 62
Neuroimmunomodulation and heat stress in poultry
Calefi, A. S., Quinteiro-Filho, W. M., Ferreira, A. J. P., & Palermo‐Neto, J. (2017) · World s Poultry Science Journal · doi:10.1017/s0043933917000472 · Cited by 65
“The CRH peptides related to CRH and CRH receptors have been included in the list of mechanisms that modulate energy metabolism (Gillies et al., 1982).”
BackgroundVasopressin and metabolic disorders: translation from experimental models to clinical use
Nakamura, K., Velho, G., & Bouby, N. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12649 · Cited by 63
Corticotropin-releasing hormone challenge in prepubertal major depression
Birmaher, B. B., Dahl, R. E., Perel, J. M., Williamson, D. E., Nelson, B., Stull, S. D., Kaufman, J., Waterman, G. S., Rao, U., Nguyen, N., et al. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00177-8 · Cited by 68
Rots, N. Y., Cools, A. R., de Jong, J., & De Kloet, E. R. (1995) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1995.tb00678.x · Cited by 62
“Accordingly, it might well be that additional ACTH secretagogues such as vasopressin were also increased, since it is known that this peptide sensitizes the pituitary for CRH (19, 20).”
BackgroundMethodENGLER, D., PHAM, T., LIU, J.-P., FULLERTON, M. J., CLARKE, I. J., & FUNDER, J. W. (1990) · Endocrinology · doi:10.1210/endo-127-4-1956 · Cited by 61
GIBBS, D. M. (1985) · Endocrinology · doi:10.1210/endo-116-2-723 · Cited by 61
Physiology of Neural Pathways Affecting CRH Secretion
ASSENMACHER, I., SZAFARCZYK, A., Alonso, G., IXART, G., & Barbanel, G. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb24957.x · Cited by 61
Corticotropin-Releasing Hormone and Arginine Vasopressin in Depression
Bao, A., & Swaab, D. F. (2010) · Vitamins and hormones · doi:10.1016/s0083-6729(10)82018-7 · Cited by 68
Sebaai, N., Lesage, J., Breton, C., Vieau, D., & Deloof, S. (2004) · Neuroendocrinology · doi:10.1159/000078098 · Cited by 57
Kanbay, M., Yılmaz, S., Dinçer, N., Ortíz, A., Sag, A. A., Covic, A. C., Sánchez‐Lozada, L. G., Lanaspa, M. A., Cherney, D. Z. I., Johnson, R. J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01049 · Cited by 66
Effects of alcohol on the synthesis and expression of hypothalamic peptides
Madeira, M. D., & Paula-Barbosa, M. M. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00131-2 · Cited by 70
Ma, S., Shipston, M. J., Morilak, D., & Russell, J. A. (2005) · Endocrinology · doi:10.1210/en.2004-1368 · Cited by 60
TSAGARAKIS, S., NAVARA, P., REES, L. H., BESSER, M., & GROSSMAN, A. (1989) · Endocrinology · doi:10.1210/endo-124-5-2330 · Cited by 60
Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat
Aguilera, G., & Rabadan‐Diehl, C. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.tb00004.x · Cited by 57
Molecular pharmacology of V1a vasopressin receptors
Howl, J., & Wheatley, M. (1995) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)00016-t · Cited by 62
Mitochondria, Oxytocin, and Vasopressin: Unfolding the Inflammatory Protein Response
Bordt, E. A., Smith, C. J., Demarest, T. G., Bilbo, S. D., & Kingsbury, M. A. (2019) · Neurotoxicity Research · doi:10.1007/s12640-018-9962-7 · Cited by 58
“Parvocellular neurons within the PVN also release AVP into the anterior pituitary where it augments the neuroendocrine stress response by stimulating adrenocorticotropic hormone release, leading to the release of glucocorticoids from the adrenal cortex (Gillies et al. 1982).”
Stress and the pituitary-adrenal axis
Gaillard, R.-C., & Al‐Damluji, S. (1987) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(87)80066-6 · Cited by 63
Pang, S., & Clark, A. C. (1990) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(90)90068-e · Cited by 58
Arginine Vasopressin in the Testis: An Intragonadal Peptide Control System*
Kasson, B. G., Adashi, E. Y., & Hsueh, A. J. W. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-2-156 · Cited by 60
Bäckström, T., Schjolden, J., Øverli, Ø., Thörnqvist, P., & Winberg, S. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.11.008 · Cited by 62
“In this context, it should be noted that Pottinger and Carrick (2001b) reported that HR and LR trout expressed differences in interrenal sensitivity to ACTH (higher in HR trout) but not in post-stress ACTH levels.”
InfluentialKanczkowski, W., Sue, M., & Bornstein, S. R. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00156 · Cited by 61
“An early morning release of adrenocorticotropic hormone (ACTH) into circulation is enhanced by increased concentrations of corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) in the hypophyseal portal system of anterior pituitary (10, 11).”
BackgroundCorticotropin-releasing factor (CRF) — a review
Emeric-Sauval, E. (1986) · Psychoneuroendocrinology · doi:10.1016/0306-4530(86)90014-4 · Cited by 57
Mune, T., Murase, H., Yamakita, N., Fukuda, T., Murayama, M. A., Miura, A., Suwa, T., Hanafusa, J., Daido, H., Morita, H., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020067 · Cited by 65
“The renal V2 receptor coupled to A kinase mediates well-known antidiuretic action (3), and the pituitary-specific V3 (V1b) receptor coupled to C kinase stimulates ACTH secretion and potentiates corticotropin releasing factor-evoked ACTH release (4, 5).”
BackgroundChapter 5 Organization of the stress response at the anatomical level
Palkovits, M. (1987) · Progress in brain research · doi:10.1016/s0079-6123(08)60195-8 · Cited by 57
Bilezikjian, L. M., Woodgett, J. R., Hunter, T., & Vale, W. W. (1987) · Molecular Endocrinology · doi:10.1210/mend-1-8-555 · Cited by 58
Norman, L. J., & Challis, J. R. G. (1987) · Endocrinology · doi:10.1210/endo-120-3-1052 · Cited by 57
A novel GABA-mediated corticotropin-releasing hormone secretory mechanism in the median eminence
Kakizawa, K., Watanabe, M., Mutoh, H., Okawa, Y., Yamashita, M., Yanagawa, Y., Itoi, K., Suda, T., Oki, Y., & Fukuda, A. (2016) · Science Advances · doi:10.1126/sciadv.1501723 · Cited by 58
“2016; 2 : e1501723 17 August 2016 anterior pituitary (18), were also not significantly different between genotypes (wild type, 3.”
BackgroundApproach to the Patient: “Utility of the Copeptin Assay”
Christ‐Crain, M., Refardt, J. C., & Winzeler, B. F. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac070 · Cited by 56
Holmes, M. C., Catt, K. J., & Aguilera, G. (1987) · Endocrinology · doi:10.1210/endo-121-6-2093 · Cited by 56
Handa, R. J., Sharma, D., & Uht, R. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00065 · Cited by 50
“Nonetheless, both vasopressin and oxytocin can stimulate ACTH secretion even in the absence of CRH (Gillies et al., 1982).”
BackgroundRabadan-Diehl, C. (1996) · Endocrinology · doi:10.1210/en.137.9.3808 · Cited by 55
“portant role in the control of ACTH secretion, mostly by potentiating the stimulatory effect of CRH (3-4).”
BackgroundSaphier, D., & Ovadia, H. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90577-v · Cited by 55
Childs, G. V., Westlund, K. N., & Unabia, G. C. (1989) · Endocrinology · doi:10.1210/endo-125-1-554 · Cited by 55
Howlett, T. A., PRICE, J., HALE, A. C., Doniach, I., REES, L. H., Wass, J. A. H., & BESSER, G. M. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb01069.x · Cited by 55
IRVINE, C. H. G., ALEXANDER, S. L., & DONALD, R. A. (1989) · Endocrinology · doi:10.1210/endo-124-6-3102 · Cited by 55
Murat, B., Devost, D., Andrés, M., Mion, J., Boulay, V., Corbani, M., Zingg, H. H., & Guillon, G. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1202 · Cited by 54
Velho, G., Ragot, S., Boustany, R. E., Saulnier, P., Fraty, M., Mohammedi, K., Fumeron, F., Potier, L., Marre, M., Hadjadj, S., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0753-5 · Cited by 57
Deuster, P. A., Petrides, J. S., Singh, A., Lucci, E. B., Chrousos, G. P., & Gold, P. W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5110 · Cited by 50
Kuhn, J., Proeschel, M. F., Seurin, D., BERTAGNA, X. Y., LUTON, J. P., & Girard, F. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90443-9 · Cited by 54
SCHWARTZ, J., & VALE, W. (1988) · Endocrinology · doi:10.1210/endo-122-4-1695 · Cited by 55
DOHANICS, J., HOFFMAN, G. E., & VERBALIS, J. G. (1991) · Endocrinology · doi:10.1210/endo-128-1-331 · Cited by 54
An introduction to the HPA axis
Fulford, A. J., & Harbuz, M. S. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80006-9 · Cited by 70
Morimoto, I., Yamamoto, S., Kai, K., Fujihira, T., Morita, E., & Eto, S. (2000) · Neuroendocrinology · doi:10.1159/000054557 · Cited by 53
“AVP secretion into the portal blood potentiates the effect of CRH on ACTH secretion from the anterior pituitary [”
BackgroundLocalization of leptin receptor immunoreactivity in the lean and obese Zucker rat brain
Yarnell, D. O., Knight, D. S., Hamilton, K. A., Tulp, O. L., & Tso, P. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01388-7 · Cited by 56
Selective effects of ECT on hypothalamic—pituitary activity
Whalley, L. J., Eagles, J. M., Bowler, G. M. R., Bennie, J. G., Dick, H. R., McGuire, R. J., & Fink, G. (1987) · Psychological Medicine · doi:10.1017/s0033291700024855 · Cited by 53
Neuron‐specific expression and physiological regulation of bovine vasopressin transgenes in mice.
Ang, H. L., Carter, D., & Murphy, D. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05894.x · Cited by 53
10 Neuroendocrinology of the hypothalamo—pituitary—adrenal axis in pregnancy and the puerperium
Smith, R., & Thomson, M. (1991) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80102-8 · Cited by 52
MAKARA, G. B., MERGL, Z., & ZELENA, D. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.018 · Cited by 51
“(4) AVP coming from the parvocellular CRH neurons of the PVN potentiates CRH.”
BackgroundDhillo, W. S., Small, C. J., Jethwa, P. H., Russell, S. H., Gardiner, J. V., Bewick, G. A., Seth, A., Murphy, K. G., Ghatei, M. A., & Bloom, S. R. (2003) · Endocrinology · doi:10.1210/en.2002-220902 · Cited by 48
“CRH and AVP are synthesized in the PVN and are major ACTH secretagogues (13, 14).”
BackgroundEndogenous vasopressin contributes to hypothalamic-pituitary-adrenocortical alterations in aged rats
Hatzinger, M., Wotjak, C., Naruo, T., Simchen, R., Keck, M., Landgraf, R., Holsboer, F., & Neumann, I. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1640197 · Cited by 52
“large number of studies in which these neuropeptides were co-administered ( Gillies et al. 1982, von Bardeleben et al. 1985, Antoni et al. 1990).”
BackgroundGinsberg, S. D., Hof, P. R., Young, W. G., & Morrison, J. H. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903410405 · Cited by 53
Corticotropin-Releasing Factor, Corticosteroids, Stress, and Sugar
Dallman, M. F., Viau, V., Bhatnagar, S., Gómez-Oliver, F., Laugero, K. D., & Bell, M. E. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50011-1 · Cited by 65
Schmidt, E. D., Schoffelmeer, A. N. M., De Vries, T. J., Wardeh, G., Dogterom, G., Bol, J. G. J. M., Binnekade, R., & Tilders, F. J. H. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01569.x · Cited by 52
“…paraventricular nucleus (PVN), i.e. increased coproduction, corelease and cosecretion of arginine vasopressin (AVP) (Tilders et al., 1993), a neuropeptide that potentiates CRH-induced adrenocorticotropine hormone (ACTH) release from the pituitary gland (Gillies et al., 1982; Rivier et al., 1984).”
BackgroundCalcium-Dependent Control of Corticotropin Release in Rat Anterior Pituitary Cell Cultures
Abou‐Samra, A., Catt, K. J., & Aguilera, G. (1987) · Endocrinology · doi:10.1210/endo-121-3-965 · Cited by 52
Roy, A., & Campbell, M. K. (2013) · Clinical and Investigative Medicine · doi:10.25011/cim.v36i4.19951 · Cited by 49
“Furthermore, CRH and ADH themselves can also impact various systems in the body [5,6].”
BackgroundInfluentialLan, N., Yamashita, F., Halpert, A., Ellis, L., Yu, W. K., Viau, V., & Weinberg, J. (2006) · Journal of neuroendocrinology · doi:10.1111/j.1365-2826.2006.01462.x · Cited by 54
Kuwahara, S., Arima, H., Banno, R., Sato, I., Kondo, N., & Oiso, Y. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10231.2003 · Cited by 52
Normal hypothalamo–pituitary–adrenal axis function in a rat model of peripheral neuropathic pain
Bomholt, S. F., Mikkelsen, J. D., & Blackburn-Munro, G. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.005 · Cited by 61
Role of arginine vasopressin in control of ACTH and LH release during stress
Ono, N., de Castro, J. B., Khorram, O., & McCann, S. M. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90561-2 · Cited by 51
Hesketh, S., Jessop, D. S., Hogg, S., & Harbuz, M. S. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06074 · Cited by 49
“AVP is a weak solo stimulator of ACTH release that can synergistically enhance the actions of CRF upon ACTH release from pituitary corticotrophs (Gillies et al. 1982).”
BackgroundDonald, R. A., Crozier, I., Foy, S. G., Richards, M., Livesey, J., Ellis, M. J., Mattioli, L., & Ikram, H. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02489.x · Cited by 50
“There is invitro evidence (Gillies et al., 1982) that there may be another stimulatory factor, and Grossman and Tsagarakis (1989) have reviewed the evidence for a release inhibiting factor or factors.”
BackgroundPiekut, D. T., & Joseph, S. A. (1985) · Peptides · doi:10.1016/0196-9781(85)90318-3 · Cited by 52
Shalts, E., Feng, Y. J., & Ferin, M. (1992) · Endocrinology · doi:10.1210/endo.131.1.1611995 · Cited by 50
Hisano, S., Tsuruo, Y., Katoh, S., Daikoku, S., Yanaihara, N., & Shibasaki, T. (1987) · Cell and Tissue Research · doi:10.1007/bf00217321 · Cited by 50
“VP stresses this function or potentiates the CRF activity (Gillies et al. 1982; Rivier and Vale 1983; Vale et al. 1983), and enkephalin may inhibit ACTH release (Lamberts et al.”
BackgroundStress Hormones in Blood and Cerebrospinal Fluid of Conscious Sheep: Effect of Hemorrhage*
Cameron, V. A., Espiner, E. A., Nicholls, M. G., Donald, R. A., & MacFarlane, M. R. (1985) · Endocrinology · doi:10.1210/endo-116-4-1460 · Cited by 50
Adrenocorticotropic hormone and cortisol in calves after corticotropin-releasing hormone.
Veissier, I., van Reenen, C. G., Andanson, S., & Leushuis, I. E. (1999) · Journal of Animal Science · doi:10.2527/1999.7782047x · Cited by 49
Ohya, T., & Hayashi, S. (2006) · ZOOLOGICAL SCIENCE · doi:10.2108/zsj.23.23 · Cited by 49
“Grober and Sunobe (1996) found that when gobies ( Trimma okinawae ) underwent reversible sex change, the VT producing neurons changed their size.”
BackgroundCornett, L. E., Kirby, J. D., Vizcarra, J. A., Ellison, J. C., Thrash, J., Mayeux, P. R., Crew, M. D., Jones, S. M., Ali, N., & Baeyens, D. A. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00216-1 · Cited by 53
Hoffman, A., Ceda, G., & Reisine, T. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-01-00234.1985 · Cited by 49
“Thus, arginine vasopressin (AVP) (Yates et al., 1971; ulating effects of catecholamines (Heisler et al., 1983b) and the Giguere and Labrie, 1982; Gillies et al., 1982; Gillies and Lowry, inhibitory actions of somatostatin (Reisine and Axelrod, 1983) 1982; Labrie et al., 1982; Aguilera et al., 1983;…”
BackgroundThe fish neuropeptide urotensin I: Its physiology and pharmacology
Lederis, K. P., Fryer, J. N., & Yulis, C. R. (1985) · Peptides · doi:10.1016/0196-9781(85)90397-3 · Cited by 49
Chronobiology of the Hypothalamic-Pituitary-Adrenal and Renin-Angiotensin-Aldosterone Systems
Angeli, A., Gatti, G., & Masera, R. G. (1992) · Springer eBooks · doi:10.1007/978-3-642-78734-8_22 · Cited by 50
Douglas, A. J. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80014-8 · Cited by 49
The cloned avian neurohypophysial hormone receptors
Baeyens, D. A., & Cornett, L. E. (2005) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2005.09.012 · Cited by 53
Itoi, K., Mouri, T., Takahashi, K., Murakami, O., Imai, Y., Sasaki, S., YOSHINAGA, K., & Sasano, N. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90250-3 · Cited by 48
The role of oxytocin: present concepts
Jenkins, J. S., & Nussey, S. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb00333.x · Cited by 52
“Hypophysiotrophic actions of oxytocin ACTH secretion It is now well recognized that arginine vasopressin stimulates the release of ACTH both in oitro (Gillies et al., 1982) and in viuo (Liu et al., 1983), so that vasopressin is regarded as an important cofactor in the regulation of ACTH secretion.”
BackgroundNg, P. C., Wong, G., Lam, C. W. K., Lee, C. H., Wong, M. Y., Fok, T. F., Wong, W., & Chan, D. C. F. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3832 · Cited by 48
“The insulin stress test, which induces hypoglycemia and stimulates the release of other hormones, including vasopressin, catecholamines, and oxytocin (10, 11), is considered unsuitable and possibly dangerous because of its potential adverse effects on the developing brain.”
BackgroundRegulation of gene expression by corticoid hormones in the brain and spinal cord
Nicola, A. F. D., Ferrini, M. G., González, S. L., Deniselle, M. C. G., Grillo, C. A., Piroli, G. G., Saravia, F., & de Kloet, E. R. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00190-8 · Cited by 55
Itoh, H., Nakao, K., Katsuura, G., Morii, N., Yamada, T., Shiono, S., Sakamoto, M., Sugawara, A., Saito, Y., Eigyo, M., et al. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90489-1 · Cited by 48
Progesterone does not alter osmotic regulation of AVP
Calzone, W. L., Silva, C., Keefe, D. L., & Stachenfeld, N. S. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.6.r2011 · Cited by 47
“Corticotropin-releasing hormone and AVP interact at the level of the anterior pituitary (16), so we determined whether HSI induced a P[Cort] response.”
BackgroundAlexander, L. D., & Sander, L. D. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90068-x · Cited by 47
Maguire, A., Biesheuvel, C. J., Ambler, G. R., Moore, B., McLean, M. P., & Cowell, C. T. C. T. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03100.x · Cited by 53
Albeck, D. S., Hastings, N. B., & McEwen, B. S. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90083-3 · Cited by 48
Metadata
- Authors
- Gillies, G. E., Linton, E. A., & Lowry, P. J.
- Affiliations
- St Bartholomew's Hospital (GB)
- ORCID
- Linton, E. A.
- Venue
- Nature
- Published
- 1982-09
- Volume
- 299
- Issue
- 5881
- Pages
- 355-357
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2088159839
- Cited by
- 965
- References
- 20
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 6 · 2023: 10 · 2022: 12 · 2021: 7 · 2020: 12 · 2019: 16 · 2018: 10 · 2017: 16 · 2016: 20 · 2015: 12 · 2014: 20 · 2013: 16 · 2012: 17
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, vasopressin, hypothalamic neuropeptides, hypothalamic extract, hypothalamic-pituitary-adrenal axis
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Corticotropin-Releasing Hormone, Dose-Response Relationship, Drug, Drug Synergism, Hypothalamus, Vasopressins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.